| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045720909 |
| P356 | DOI | 10.1007/S00467-011-2058-8 |
| P698 | PubMed publication ID | 22083365 |
| P5875 | ResearchGate publication ID | 51798251 |
| P2093 | author name string | Franz Schaefer | |
| Guido Engelmann | |||
| Betti Schaefer | |||
| Claus Peter Schmitt | |||
| Daniel Wenning | |||
| Dieter Wittmer | |||
| P2860 | cites work | Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis | Q33345664 |
| Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure | Q33844163 | ||
| Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure | Q34083511 | ||
| Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure | Q34087222 | ||
| Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis | Q34172340 | ||
| Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial | Q34181574 | ||
| Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus. | Q34189190 | ||
| Bile salt transporters | Q34516267 | ||
| Multidrug resistance in brain tumors: roles of the blood-brain barrier | Q34520270 | ||
| What is new in uremic toxicity? | Q34589157 | ||
| Extrahepatic manifestations of cholestasis | Q34776437 | ||
| Cholestatic liver disease: pathophysiology and therapeutic options | Q34830345 | ||
| Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study | Q34999188 | ||
| Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales | Q37229333 | ||
| Peptide transport systems for opiates across the blood-brain barrier | Q37941933 | ||
| Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure | Q38464543 | ||
| Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers. | Q38467441 | ||
| Long-lasting extracorporeal albumin dialysis in a child with end-stage renal disease and severe cholestasis | Q38477280 | ||
| Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. | Q38481056 | ||
| Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS). | Q38482468 | ||
| Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. | Q38489634 | ||
| Treatment of intractable pruritus in drug induced cholestasis with albumin dialysis: a report of two cases. | Q38490835 | ||
| Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. | Q38491056 | ||
| Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. | Q38492229 | ||
| Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. | Q38496650 | ||
| Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. | Q41648408 | ||
| Why do cholestatic patients itch? | Q42108717 | ||
| Use of rifampin for severe pruritus in children with chronic cholestasis | Q42611214 | ||
| Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: a study on the pathophysiology of hepatic encephalopathy | Q43177106 | ||
| Uptake and efflux of the peptidic delta-opioid receptor agonist | Q43546834 | ||
| Health-related quality of life in chronic liver disease: the impact of type and severity of disease | Q43705846 | ||
| Intractable pruritus in patients with hepatitis C virus | Q45415935 | ||
| Therapeutic plasmapheresis for cholestatic liver diseases: study of 9 cases. | Q45793975 | ||
| Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan | Q48926127 | ||
| Treatment of intractable pruritus in patients with cholestatic jaundice by plasma exchange and plasma perfusion | Q67431231 | ||
| Removal of bile acids from the blood by hemodialysis with a polyacrylonitril membrane: treatment of pruritus of cholestatic disease | Q70400167 | ||
| Pruritus | Q73246602 | ||
| Testosterone therapy for the pruritus of obstructive jaundice | Q74038480 | ||
| Major coagulation disturbances during fractionated plasma separation and adsorption | Q80639765 | ||
| The pruritus of cholestasis | Q81410186 | ||
| P433 | issue | 5 | |
| P921 | main subject | renal dialysis | Q202301 |
| P304 | page(s) | 829-834 | |
| P577 | publication date | 2011-11-15 | |
| P1433 | published in | Pediatric Nephrology | Q15749796 |
| P1476 | title | Molecular Adsorbents Recirculating System dialysis in children with cholestatic pruritus | |
| P478 | volume | 27 |
| Q59800175 | Artificial liver support systems: what is new over the last decade? |
| Q38437179 | Comparison of two different modes of molecular adsorbent recycling systems for liver dialysis |
| Q48136011 | Improvement of refractory pruritus after lipoprotein-apheresis in arthrogryposis-renal failure-cholestasis syndrome. |
| Q42467990 | Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents |
| Q46903565 | Is the molecular adsorbent recirculating system the answer for children with acute liver failure? |
| Q38451678 | Molecular Absorbent Recirculating System therapy (MARS®) in pediatric acute liver failure: a single center experience |
| Q38125598 | Optimizing peritoneal dialysis prescription for volume control: the importance of varying dwell time and dwell volume |
| Q38062342 | The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children |
Search more.